Gluco Track Inc - Understand $gctk stock

$GCTK Market Cap: $1.78 Million

Research Board Inbox Deep Research Not Interested Shortlisted

Financial Snapshot

Revenue

$0.00

TTM

Gross Margin

Net Earnings

-$14.92M

TTM

Current Assets

$642.0K

Q3 2024

Current Liabilities

$4.611M

Q3 2024

Current Ratio

13.92%

Q3 2024

Total Assets

$826.0K

Q3 2024

Total Liabilities

$4.848M

Q3 2024

Book Value

-$4.022M

Q3 2024

Cash

$346.0K

Q3 2024

P/E

-0.1193

Nov 14, 2024 EST

Free Cash Flow

-$7.331M

TTM

Revenues

Revenue YoY Change

Revenues

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009
Revenue	$0.00	$0.00	$0.00	$0.00	$208.8K	$17.00B	$589.5K	$611.7K	$140.0K	$59.78K					$0.00
YoY Change				-100.0%	-100.0%	2883895.52%	-3.63%	336.92%	134.21%

Expenses

Cost Of Revenues

Gross Profit

Gross Profit Margin

Gross Profit

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2009
Revenue	$0.00	$0.00	$0.00	$0.00	$208.8K	$17.00B	$589.5K	$611.7K	$140.0K	$59.78K	$0.00
Cost Of Revenue
Gross Profit
Gross Profit Margin

Selling, General & Admin Expense

Research & Development

Depreciation, Depletion & Amortization

SGA Expense to Gross Profit Ratio

R&D To Gross Profit Ratio

DDA To Gross Profit Ratio

Operating Expenses Total

Operating Profits/Loss

Operational Expenses

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009
Selling, General & Admin	$2.397M	$2.462M	$2.220M	$1.585M	$2.090M	$3.521M	$7.958M	$3.386M	$2.530M	$1.818M	$1.041M	$852.9K	$970.0K	$660.0K	$170.0K
YoY Change	-2.64%	10.9%	40.06%	-24.16%	-40.64%	-55.76%	135.04%	33.82%	39.2%	74.57%	22.07%	-12.07%	46.97%	288.24%	6.25%
% of Gross Profit
Research & Development	$4.694M	$1.967M	$1.778M	$1.500M	$1.574M	$3.003M	$3.207M	$2.882M	$2.270M	$1.850M	$1.987M	$1.921M	$1.789M	$934.1K	$1.005M
YoY Change	138.64%	10.63%	18.53%	-4.69%	-47.58%	-6.39%	11.3%	26.95%	22.73%	-6.9%	3.44%	7.34%	91.56%	-7.07%	-18.94%
% of Gross Profit
Depreciation & Amortization	$13.00K	$23.00K	$42.00K	$47.00K	$50.59K	$58.79K	$67.88K	$59.58K	$40.00K	$34.68K	$33.68K	$25.55K	$23.05K	$19.15K	$20.84K
YoY Change	-43.48%	-45.24%	-10.64%	-7.1%	-13.95%	-13.39%	13.93%	48.95%	15.33%	2.97%	31.86%	10.85%	20.32%	-8.08%	4.19%
% of Gross Profit
Operating Expenses	$7.104M	$4.432M	$4.040M	$3.132M	$3.714M	$6.582M	$11.17M	$6.268M	$4.800M	$3.667M	$3.028M	$2.774M	$1.789M	$934.1K	$1.005M
YoY Change	60.29%	9.7%	28.99%	-15.68%	-43.57%	-41.05%	78.15%	30.57%	30.89%	21.11%	9.17%	55.01%	91.56%	-7.07%	-28.21%
Operating Profit	-$7.104M	-$4.432M	-$4.040M							-$3.607M	-$3.028M	-$2.774M	-$2.333M	-$1.391M	-$1.170M
YoY Change	60.29%	9.7%								19.14%	9.17%	18.86%	67.8%	18.83%

Interest Expenses

Interest Expenses To Operating Income %

Other Expense/Income

Interest & Other Expense/Income

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009
Interest Expense	$7.000K	$11.00K	$26.00K	$98.00K	-$10.52K	-$176.8K	$247.1K	$246.1K	-$1.190M	$30.00K	-$110.0K	-$20.00K	-$10.00K	$30.00K	-$20.00K
YoY Change	-36.36%	-57.69%	-73.47%	-1031.56%	-94.05%	-171.57%	0.38%	-120.68%	-4066.67%	-127.27%	450.0%	100.0%	-133.33%	-250.0%	-81.82%
% of Operating Profit
Other Income/Expense, Net		-$14.00K	-$53.00K	$338.0K						$6.560M	-$6.660M	$30.00K	-$20.00K	-$1.430M	-$10.00K
YoY Change		-73.58%	-115.68%							-198.5%	-22300.0%	-250.0%	-98.6%	14200.0%	-50.0%

Income/Loss

Pretax Income

Income Tax

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

Net Profits/Loss YoY Change

Basic EPS

Net Income To Revenue Ratio

Pretax & Net Income

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009
Pretax Income	-$7.097M	-$4.435M	-$4.067M	-$2.696M	-$3.516M	-$6.715M	-$10.33M	-$5.410M	-$5.840M	$2.980M	-$9.797M	-$2.772M	-$2.364M	-$2.788M	-$1.200M
YoY Change	60.02%	9.05%	50.85%	-23.33%	-47.64%	-34.98%	90.93%	-7.37%	-295.95%	-130.42%	253.38%	17.26%	-15.21%	132.37%	-21.57%
Income Tax															$0.00
% Of Pretax Income
Net Earnings	-$7.097M	-$4.435M	-$4.067M	-$2.696M	-$3.516M	-$6.715M	-$10.33M	-$5.410M	-$6.290M	$2.980M	-$9.797M	-$2.772M	-$2.364M	-$2.788M	-$1.202M
YoY Change	60.02%	9.05%	50.85%	-23.33%	-47.64%	-34.98%	90.93%	-13.99%	-311.04%	-130.42%	253.38%	17.26%	-15.21%	131.93%	-21.37%
Net Earnings / Revenue					-1684.3%	-0.04%	-1752.25%	-884.39%	-4492.86%	4986.07%
Basic Earnings Per Share	$0.38	$0.29	$0.26							$0.37	-$1.95	-$0.52
Diluted Earnings Per Share	-$0.34	-$0.29	-$263.2K	-$178.8K	-$295.0K	-$10.40M	-$21.36M	-$12.15M	-$14.97	$0.37	-$1.95	-$0.52	-$6.04	-$8.98	-$3.87

Assets & Liabilities

Cash & Short-Term Investments

Cash & Equivalents

Cash To Operating Expenses Ratio

Inventory

Receivables

Total Short-Term Assets

Property, Plant And Equipment

Long-Term Investments

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

Accounts Payable

Short-Term Debt

Long Term Debt Due

Total Short-Term Liabilities

Long-Term Debt

Other Long-Term Liabilities

Total Long-Term Liabilities

Total Liabilities

Short-Term To Long-Term Debt Ratio

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

Assets & Liabilities

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009
Cash & Short-Term Investments	$4.492M	$2.312M	$6.062M	$9.823M	$418.6K	$97.08K	$53.78K	$148.8K	$610.0K	$5.830M	$2.390M	$540.0K	$1.900M	$1.490M	$60.00K
YoY Change	94.29%	-61.86%	-38.29%	2246.52%	331.21%	80.51%	-63.87%	-75.6%	-89.54%	143.93%	342.59%	-71.58%	27.52%	2383.33%
Cash & Equivalents	$4.492M	$2.312M	$6.062M	$9.823M	$418.6K	$97.08K	$53.78K	$148.8K	$610.0K	$5.830M	$2.390M	$540.0K	$1.900M	$1.490M	$60.00K
Short-Term Investments
Other Short-Term Assets	$376.0K	$67.00K	$43.00K	$56.00K	$44.66K	$23.29K	$94.14K	$357.0K	$270.0K	$120.0K	$90.00K	$80.00K	$90.00K	$70.00K	$20.00K
YoY Change	461.19%	55.81%	-23.21%	25.39%	91.76%	-75.26%	-73.63%	32.22%	125.0%	33.33%	12.5%	-11.11%	28.57%	250.0%
Inventory			$0.00	$284.0K	$184.6K	$171.0K	$957.4K	$1.420M	$820.0K	$80.00K
Prepaid Expenses
Receivables			$0.00	$66.00K	$70.16K	$22.78K	$121.8K	$92.06K	$20.00K	$20.00K			$0.00	$10.00K	$10.00K
Other Receivables			$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00			$0.00	$0.00	$0.00
Total Short-Term Assets	$4.868M	$2.379M	$6.105M	$10.23M	$718.0K	$314.2K	$1.227M	$2.018M	$1.710M	$6.050M	$2.480M	$620.0K	$1.990M	$1.580M	$100.0K
YoY Change	104.62%	-61.03%	-40.32%	1324.57%	128.57%	-74.4%	-39.18%	17.98%	-71.74%	143.95%	300.0%	-68.84%	25.95%	1480.0%
Property, Plant & Equipment	$27.00K	$40.00K	$109.0K	$315.0K	$321.0K	$149.8K	$216.8K	$240.5K	$220.0K	$120.0K	$110.0K	$70.00K	$80.00K	$60.00K	$70.00K
YoY Change	-32.5%	-63.3%	-65.4%	-1.88%	114.33%	-30.9%	-9.86%	9.3%	83.33%	9.09%	57.14%	-12.5%	33.33%	-14.29%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$10.00K	$19.00K	$51.00K	$62.00K	$57.09K	$224.3K	$225.1K	$203.0K	$200.0K	$180.0K	$170.0K	$120.0K	$110.0K	$130.0K	$100.0K
YoY Change	-47.37%	-62.75%	-17.74%	8.6%	-74.54%	-0.39%	10.9%	1.5%	11.11%	5.88%	41.67%	9.09%	-15.38%	30.0%
Total Long-Term Assets	$37.00K	$59.00K	$160.0K	$377.0K	$378.1K	$374.0K	$441.9K	$443.5K	$420.0K	$300.0K	$280.0K	$190.0K	$190.0K	$190.0K	$160.0K
YoY Change	-37.29%	-63.13%	-57.56%	-0.3%	1.09%	-15.35%	-0.35%	5.58%	40.0%	7.14%	47.37%	0.0%	0.0%	18.75%
Total Assets	$4.905M	$2.438M	$6.265M	$10.61M	$1.096M	$688.2K	$1.669M	$2.461M	$2.130M	$6.350M	$2.760M	$810.0K	$2.180M	$1.770M	$260.0K
YoY Change
Accounts Payable	$839.0K	$672.0K	$631.0K	$869.0K	$1.534M	$2.064M	$2.420M	$1.635M	$1.080M	$100.0K	$50.00K	$120.0K	$70.00K	$60.00K	$30.00K
YoY Change	24.85%	6.5%	-27.39%	-43.35%	-25.68%	-14.7%	48.04%	51.36%	980.0%	100.0%	-58.33%	71.43%	16.67%	100.0%
Accrued Expenses		$341.0K	$252.0K	$84.00K	$142.1K					$440.0K		$300.0K	$210.0K	$210.0K	$110.0K
YoY Change		35.32%	200.0%	-40.88%								42.86%	0.0%	90.91%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$40.00K	$0.00	$20.00K	$90.00K
YoY Change											-100.0%		-100.0%	-77.78%
Long-Term Debt Due									$0.00	$450.0K
YoY Change									-100.0%
Total Short-Term Liabilities	$1.512M	$1.013M	$883.0K	$1.345M	$2.272M	$3.222M	$3.686M	$2.348M	$1.510M	$1.000M	$310.0K	$460.0K	$280.0K	$290.0K	$240.0K
YoY Change	49.26%	14.72%	-34.35%	-40.81%	-29.47%	-12.6%	56.97%	55.51%	51.0%	222.58%	-32.61%	64.29%	-3.45%	20.83%
Long-Term Debt	$196.0K	$195.0K	$210.0K	$197.0K	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
YoY Change	0.51%	-7.14%	6.6%
Other Long-Term Liabilities		$0.00	$17.00K	$82.00K	$235.5K	$339.9K	$1.137M	$1.021M	$660.0K	$2.430M	$9.150M	$860.0K	$930.0K	$880.0K	$800.0K
YoY Change		-100.0%	-79.27%	-65.18%	-30.71%	-70.1%	11.35%	54.65%	-72.84%	-73.44%	963.95%	-7.53%	5.68%	10.0%
Total Long-Term Liabilities	$196.0K	$195.0K	$227.0K	$279.0K	$235.5K	$339.9K	$1.137M	$1.021M	$660.0K	$2.430M	$9.150M	$860.0K	$930.0K	$880.0K	$800.0K
YoY Change	0.51%	-14.1%	-18.64%	18.47%	-30.71%	-70.1%	11.35%	54.65%	-72.84%	-73.44%	963.95%	-7.53%	5.68%	10.0%
Total Liabilities	$1.708M	$1.208M	$1.110M	$1.624M	$2.508M	$3.561M	$4.823M	$3.369M	$2.170M	$3.430M	$9.460M	$1.320M	$1.210M	$1.170M	$1.040M
YoY Change	41.39%	8.83%	-31.65%	-35.24%	-29.59%	-26.15%	43.15%	55.25%	-36.73%	-63.74%	616.67%	9.09%	3.42%	12.5%

Ownership

Basic Shares Outstanding

Diluted Shares Outstanding

Preferred Stock

Treasury Stock Shares

Stock Issuance & Repurchase

Ownership Data

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012
Basic Shares Outstanding	20.76M shares	15.47M shares	15.45M shares							5.305M shares	5.326M shares	5.315M shares
Diluted Shares Outstanding	20.76M shares	15.47M shares		196.0M shares	154.9M shares	8.397M shares	6.285M shares	5.789M shares	5.477M shares	5.349M shares	5.326M shares	5.315M shares
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Book Value

Free Cash Flow

Free Cash Flow YoY

Free Cash Flow Margin

Dividends

Stock Price

Market Cap: $1.7801 Million

About GlucoTrack Inc

GlucoTrack Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Rutherford, New Jersey and currently employs 6 full-time employees. The company went IPO on 2013-04-09. GlucoTrack, Inc. is focused on the design, development, and commercialization of novel technologies for people with diabetes. The firm is developing an implantable continuous glucose monitoring (CGM) for use by Type 1 diabetes patients as well as insulin-dependent Type 2 patients. The company is developing an implantable continuous blood glucose monitor (CBGM). This product is designed to have an approximately two-year implant longevity without the requirement for any wearable components. The CBGM utilizes an intravascular approach, in which the device is implanted subcutaneously and connected to a lead that is placed directly into a blood vessel. This facilitates continuous blood glucose measurements with zero lag time. The firm is also developing the Glucotrack CBGM a companion mobile application and a cloud-based solution to provide real time, data-driven personalized tools to effectively help a user manage their diabetes and assist healthcare providers with making treatment decisions.

Industry: Surgical & Medical Instruments & Apparatus Peers: Check Cap Ltd Inspira Technologies Oxy BHN Ltd